MEHMET OKCU to Prognosis
This is a "connection" page, showing publications MEHMET OKCU has written about Prognosis.
Connection Strength
0.537
-
Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma. Pediatr Blood Cancer. 2025 Mar; 72(3):e31477.
Score: 0.112
-
Rhabdomyosarcoma. Curr Probl Cancer. 2008 Jan-Feb; 32(1):7-34.
Score: 0.035
-
Clinical Correlates of Anxiety and Depression After Diagnosis of a Pediatric Brain Tumor. Pediatr Blood Cancer. 2026 Feb; 73(2):e70065.
Score: 0.030
-
Disparities in Growth Hormone Deficiency Screening, Evaluation, Diagnosis, and Treatment Among at-Risk Childhood Cancer Survivors in the US. Pediatr Blood Cancer. 2026 01; 73(1):e32124.
Score: 0.030
-
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. JCO Precis Oncol. 2025 Feb; 9:e2400556.
Score: 0.028
-
Indications and Outcomes for Tracheostomies in Pediatric Oncology Patients-A Single Center Study. Pediatr Blood Cancer. 2025 Feb; 72(2):e31451.
Score: 0.028
-
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma. Neuro Oncol. 2024 Oct 03; 26(10):1912-1920.
Score: 0.028
-
The impact of margins and re-resection in pediatric synovial sarcoma. Cancer Med. 2024 Sep; 13(17):e70207.
Score: 0.027
-
Standardizing the evaluation and management of iron deficiency anemia secondary to heavy menstrual bleeding in the emergency department. Pediatr Blood Cancer. 2024 Oct; 71(10):e31222.
Score: 0.027
-
Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. J Clin Oncol. 2003 Apr 15; 21(8):1602-11.
Score: 0.025
-
Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia. Sci Rep. 2021 10 04; 11(1):19613.
Score: 0.022
-
Treatment of central giant cell granuloma in children with denosumab. Pediatr Blood Cancer. 2021 03; 68(3):e28778.
Score: 0.021
-
Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor. J Neurooncol. 2020 Jan; 146(1):147-156.
Score: 0.020
-
Cognitive mediators of adaptive functioning outcomes in survivors of pediatric brain tumors treated with proton radiotherapy. Pediatr Blood Cancer. 2020 02; 67(2):e28064.
Score: 0.020
-
Pilot study of DNA methylation-derived neutrophil-to-lymphocyte ratio and survival in pediatric medulloblastoma. Cancer Epidemiol. 2019 04; 59:71-74.
Score: 0.019
-
Alveolar soft part sarcoma in children and young adults: A report of 69 cases. Pediatr Blood Cancer. 2018 05; 65(5):e26953.
Score: 0.017
-
Neuroendocrine Tumor of the Appendix in Children. J Pediatr Hematol Oncol. 2017 03; 39(2):97-102.
Score: 0.016
-
Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. Neuro Oncol. 2009 Dec; 11(6):825-32.
Score: 0.010
-
Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma. Mol Cancer Ther. 2009 Aug; 8(8):2461-9.
Score: 0.010
-
Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastoma. J Pediatr Surg. 2007 Jan; 42(1):148-52.
Score: 0.008
-
Synovial sarcoma in children: surgical lessons from a single institution and review of the literature. J Am Coll Surg. 2001 Mar; 192(3):305-13.
Score: 0.005